During the period from 1987 to 2007, our understanding of nervous system-T lymphocyte bi-directional communication advanced exponentially. Progress in exploring these relationships was aided by the constant development of new, cutting-edge technologies, and by a steady growth in interest, and number, of scientists who recognized the need to conduct cross-disciplinary research. In this brief review of 20 years of Brain, Behavior, and Immunity (BBI), we highlight just a small number of the important studies published in the journal that collectively have provided the foundation for our current understanding of brain, behavior, and, specifically, T cells.
Introduction
In the inaugural issue, T lymphocyte function was established as an important topic for manuscripts to be published in Brain, Behavior, and Immunity (BBI). Volume 1, Issue 1, published in March of 1987, included a paper from Glaser et al. (Glaser et al., 1987) documenting that killing of Epstein-Barr virus (EBV) infected B lymphocytes by mononuclear cells (likely cytotoxic T cells) from EBV seropositive medical students was significantly diminished during periods of school examinations compared to baseline (non-examination) periods of time. Significant increases in psychological distress (as measured by the General Severity Index of the Brief Symptom Inventory) were also observed during periods of examination compared to non-examination ( Fig. 1) .
Also in this first issue of BBI were manuscripts from Bovbjerg et al. (1987a Bovbjerg et al. ( , 1987b ) on conditioned enhancement of T cell-mediated delayed type hypersensitivity in mice, and from Kusnecov et al. (1987) examining the effects of b-endorphin on lymphocyte proliferation and interleukin-2 (IL-2) production. The authors reported that in vivo infusion of rats with b-endorphin was associated with an enhancement of the in vitro proliferative response of spleen cells to the potent, but non-specific, T cell mitogen concanavalin A (Con A). There was no effect of treatment on levels of the T cell cytokine IL-2 in culture supernatants, leading the investigators to conclude that changes in IL-2 production do not occur in association with the increase in proliferation induced by b-endorphin.
These three papers-among the very first in the 20-year history of BBI-set a standard of excellence for all of the manuscripts that have followed. It is certainly worth noting (happily) that Drs. Glaser, Bovbjerg, and Kusnecov, as well as many of their collaborators in 1987, remain important contributors to the journal and the field of psychoneuroimmunology in 2007. Importantly, their papers highlight some of the powerful tools we have used, and still use, to investigate brain to immune system modulation: psychological stress, Pavlovian conditioning, and in vivo or in vitro exogenous neurohormone administration. They also utilized state-of-the art, circa 1987, tools available for probing immune function. Although in 2007, we have advanced to using more sophisticated methods for examining T cell specific cytokine and effector responses, as well understanding T cell signaling pathways at the molecular level, we can still appreciate the value in a simple assay that 
